Axon Stock Is Up 34% in a Week. Here’s Where It Could Go in 2026

Key Stats for Axon Stock

• Current Price: $595.00
• Target Price (Mid): ~$1,636
• Street Target: ~$662
• Potential Total Return: ~174%
• Annualized IRR: ~25% / year
• Earnings Reaction: +10.63% (5/6/26)
• Max Drawdown: 60.28% (4/10/26)

Now Live: Discover how much upside your favorite stocks could have using TIKR’s new Valuation Model (It’s free) >>>

What Happened?

Axon Enterprise (AXON) has spent most of 2026 confusing the people who own it. The stock is up about 34% over the past week and roughly 44% over three months, yet it is still down around 25% year to date and sits well below its 52-week high of $885.92. Bulls see a public safety franchise compounding revenue above 30% for nine straight quarters. Bears see a stock at 71x forward earnings that just rode a political headline higher. The question the market cannot cleanly answer is whether the recent surge rests on anything more durable than a contract rumor.

That is why a quieter event matters more than the one grabbing headlines. On June 24, Axon hosted a customer webinar with three law enforcement leaders, and what they described was not a sales pitch. It was a live look at why the drone and AI demand showing up in Axon’s financials is becoming structural. For investors trying to separate signal from noise, their words are the more useful data.

The Catalyst Everyone Is Watching

The move has an obvious trigger. Federal disclosures showed President Donald Trump bought between $1 million and $5 million of Axon stock on February 10, and two weeks later, Immigration and Customs Enforcement posted a notice seeking a five-year, $220 million Taser contract for about 17,800 devices. Procurement experts told CNBC the specifications appear to match only Axon’s TASER 10. When the story resurfaced in late June, the stock jumped more than 34% in a week.

Two cautions belong in the same breath as that number. The contract has not been awarded, and reporting attributes the delay to leadership turnover at the Department of Homeland Security. Axon’s own incumbent ICE Taser contract, worth about $16.1 million, lapses August 21, 2026. So part of this rally prices in federal revenue that is real in prospect but unconfirmed in timing. Investors betting on the headline alone are betting on Washington’s calendar.

What Axon’s Customers Actually Said

Strip away the politics, and the June 24 webinar delivered the sturdier story. Redmond, Washington Police Chief Darrell Lowe described how a drone as a first responder, meaning a drone dispatched to a scene before an officer, has changed the economics of a call. His running joke was that the loudest internal skeptics became the first officers on the radio asking if the drone was available, because it “is going to get there in 90 seconds and likely cancel them from having to respond to the call.” That is the return-on-investment case for Axon’s platform, stated by the buyer, not the seller.

Overland Park, Kansas Police Chief Doreen Jokerst put a number on it. She said her department’s drone program responds “26% faster” than an officer and that she signed the largest tech contract in the department’s history with Axon in under a year. Host Mike Wagers, Axon’s Chief Customer Officer, added that agencies with these programs now see drones handling 20% to 40% of calls, sometimes arriving before dispatch finishes relaying the address. Demand like that does not reverse when a news cycle ends.

The AI adoption was just as concrete. Jokerst described running Draft One, Axon’s report-writing tool, and Axon Standards, its body-camera review system, across daily operations. Walton County, Florida Sheriff Michael Adkinson framed his whole buying philosophy around Axon’s pitch: he wants systems that touch multiple parts of the agency at once, saying he would “rather have that 80% that works across the board in a system than individual superstars.” That is the exact logic behind Axon’s bundled AI Era Plan, and it is why the platform is hard for point-solution rivals to dislodge.

The Numbers Behind the Words

The webinar color lines up with the financials. Axon reported Q1 2026 revenue of $807.35 million, up 34% year over year, its ninth straight quarter above 30% growth. Software and Services revenue grew 35%, AI product revenue grew more than 700%, and the Dedrone counter-drone unit jumped roughly 300%. Future contracted bookings, essentially the order backlog, grew 44% to $14.3 billion. Management raised full-year 2026 revenue growth guidance to a range of 30% to 32%.

Axon President Josh Isner made the federal ambition explicit, telling investors at the William Blair Growth Stock Conference on June 4 that federal law enforcement “is a lot better of a market for us” than defense work. That single line reframes the ICE story: the Taser deal is not a one-off, it is the visible edge of a channel management is deliberately building. It matters because it turns a political headline into a repeatable revenue motion.

See historical and forward estimates for Axon stock (It’s free!) >>>

Valuation: The Hard Part

Here is where the tension is real. Even after a punishing year, Axon is not cheap. It trades at a next-twelve-months P/E of about 71x and an EV/EBITDA of around 49x. Against aerospace and defense peers, the premium is stark: the peer group mean forward P/E is about 48x and the median around 31x, with names like RTX at roughly 29x and Lockheed Martin near 18x. Axon carries a multiple more than double its median peer because it is growing several times faster, but that premium leaves no cushion for execution stumbles.

The more apt comparison is Motorola Solutions, the closest public safety peer, which grew Q1 sales about 7% against Axon’s 34%. That growth gap is the entire bull argument for the multiple. The bear argument is that Axon’s free cash flow was just $75.08 million in 2025, down 77.2%, and that heavy spending on AI, inventory, and acquisitions has kept reported profitability thin while the stock still prices in years of flawless compounding. Both things are true at once, and the recent rally has widened the gap between price and proof.

See how Axon performs against its peers in TIKR (It’s free!) >>>

TIKR Advanced Model Analysis

• Target Price (Mid): ~$1,636
• Potential Total Return: ~174%
• Annualized IRR: ~25% / year

See analysts’ growth forecasts and price targets for Axon stock (It’s free!) >>>

The two revenue drivers are the AI Era Plan, now attaching across nearly all large domestic law enforcement agencies, and Dedrone counter-drone deployments shifting from event-based to permanent city installations. Those support the model’s mid-case revenue CAGR of around 23%. The margin driver is net income margin expanding toward around 19% as higher-margin software scales against the current hardware-heavy mix. The primary risk is federal and public-sector budget dependence, a reliance Axon flags in its own filings through non-appropriation clauses that let agencies walk away.

The upside case: if software attach rates and counter-drone adoption hold, the model reaches a target roughly 174% above today at about 25% annualized. 

The downside case: if margin expansion stalls or federal timing slips, a stock at 71x forward earnings can re-rate lower fast, as the 60.28% drawdown to April 10, 2026, already showed.

Conclusion

The webinar answered the question the headline could not. Axon’s demand is being pulled by operators who now measure response times in seconds and build their agencies around one ecosystem. That is the durable part. The fragile part is the price. At 71x forward earnings, the stock has already borrowed years of that compounding.

The next real test is Q2 2026 earnings, expected around early August, which lands close to the August 21 lapse of the incumbent ICE contract. Watch two things: whether adjusted EBITDA margin expands toward the guided ~25% level, confirming the software-margin thesis, and whether federal bookings show any traction. Margin expansion plus a federal signal is the green light. Flat margins or another quarter of federal silence, with the stock still near 71x forward, is the warning. The customers have made their case. Now the income statement has to.

See what stocks billionaire investors are buying so you can follow the smart money with TIKR.

Should You Invest in Axon?

The only way to really know is to look at the numbers yourself. TIKR gives you free access to the same institutional-quality financial data that professional analysts use to answer exactly that question.

Pull up Axon, and you’ll see years of historical financials, what Wall Street analysts expect for revenue and earnings in the quarters ahead, how valuation multiples have moved over time, and whether price targets are trending up or down.

You can build a free watchlist to track Axon alongside every other stock on your radar. No credit card required. Just the data you need to decide for yourself.

Analyze Axon on TIKR Free →

Looking for New Opportunities?

• See what stocks billionaire investors are buying so you can follow the smart money.
• Analyze stocks in as little as 5 minutes with TIKR’s all-in-one, easy-to-use platform.
• The more rocks you overturn… the more opportunities you’ll uncover. Search 100K+ global stocks, global top investor holdings, and more with TIKR.

Disclaimer:

Please note that the articles on TIKR are not intended to serve as investment or financial advice from TIKR or our content team, nor are they recommendations to buy or sell any stocks. We create our content based on TIKR Terminal’s investment data and analysts’ estimates. Our analysis might not include recent company news or important updates. TIKR has no position in any stocks mentioned. Thank you for reading, and happy investing!